Incorporation of galactose into blood-groups(ABH) precursor substance by lactose synthetase from human milk. Effects on cross reactivity with anti-type-14 pneumococcus serum.
D000017:ABO Blood-Group System / Q000096:biosynthesis*; D000907:Antibodies, Bacterial; D001665:Binding Sites; D001789:Blood Group Antigens; D001798:Blood Proteins / Q000096:biosynthesis; D002247:Carbon Isotopes; D003429:Cross Reactions; D005260:Female; D005643:Fucose; D005690:Galactose / Q000378:metabolism*; D006023:Glycoproteins / Q000096:biosynthesis*; D006385:Hemagglutination Inhibition Tests; D006602:Hexosyltransferases / Q000378:metabolism*; D006801:Humans; D007106:Immune Sera; D007788:Lactose Synthase / Q000378:metabolism; D008895:Milk, Human / Q000201:enzymology*; D009097:Multienzyme Complexes / Q000378:metabolism; D011233:Precipitin Tests; D012995:Solubility; D013296:Streptococcus pneumoniae / Q000276:immunology; D014867:Water
D000017:ABO Blood-Group System; D000907:Antibodies, Bacterial; D001789:Blood Group Antigens; D001798:Blood Proteins; D002247:Carbon Isotopes; D006023:Glycoproteins; D007106:Immune Sera; D009097:Multienzyme Complexes; D014867:Water; D005643:Fucose; D006602:Hexosyltransferases; D007788:Lactose Synthase; D005690:Galactose